Can BlephEx® Help Treat Recurrent Chalazion?
- Eye and Retina Specialists
- 2 days ago
- 3 min read
Recurrent chalazia can be frustrating for patients. While many chalazia resolve with warm compresses and conservative eyelid hygiene, some patients experience persistent or repeated eyelid lumps despite appropriate treatment.
Increasingly, attention has focused on the role of chronic eyelid margin disease, blepharitis and Meibomian gland dysfunction in patients with recurrent chalazion formation.
At Eye and Retina Specialists, assessment of recurrent chalazion often involves evaluation not only of the lesion itself, but also of the broader eyelid and ocular surface environment.
What Causes a Chalazion?
A chalazion develops when one of the Meibomian glands within the eyelid becomes obstructed and inflamed. These glands normally produce oils that help stabilise the tear film and reduce tear evaporation.
When gland openings become blocked, retained secretions and inflammation may lead to formation of a localised eyelid lump.
Although many chalazia occur in isolation, recurrent lesions are often associated with underlying eyelid margin disease such as:
blepharitis
Meibomian gland dysfunction
ocular rosacea
Demodex-associated eyelid inflammation
In these patients, simply treating the visible lump may not fully address the underlying process contributing to recurrence.
What Is BlephEx®?
BlephEx® is an in-office microblepharoexfoliation procedure designed to mechanically clean and exfoliate the eyelid margins using a rotating medical-grade microsponge.
The treatment is directed at removing:
bacterial biofilm
inflammatory debris
lash-base deposits
scurf and accumulated oils along the eyelid margins
BlephEx® is intended to improve the eyelid margin environment and reduce chronic inflammation associated with blepharitis and Meibomian gland dysfunction.
Blepharitis, Demodex and Recurrent Chalazion
Research has increasingly suggested that chronic eyelid inflammation may contribute to chalazion formation in some patients.
Demodex mites are microscopic organisms that inhabit eyelash follicles and sebaceous glands. Increased Demodex colonisation has been associated with chronic blepharitis, eyelid inflammation and Meibomian gland dysfunction.
Patients with Demodex-associated eyelid disease may develop:
recurrent chalazion
chronic eyelid irritation
cylindrical dandruff (“collarettes”)
recurrent styes
fluctuating vision and dry eye symptoms
Several studies have demonstrated higher rates of Demodex infestation in patients with recurrent chalazia, leading some authors to propose that Demodex-associated inflammation and gland obstruction may contribute to lesion formation.
What Does the Research Show?
A prospective randomised clinical trial by Zhu et al. published in Cornea in 2023 evaluated BlephEx® microblepharoexfoliation as adjunctive therapy in patients with acute chalazion. Fifty patients were randomised to receive either BlephEx® combined with lid hygiene or lid hygiene alone.
The study reported significantly higher chalazion resolution rates in the BlephEx® treatment group compared with lid hygiene alone (87% versus 44% resolution at one month, p = 0.007).
The authors proposed that microblepharoexfoliation may help reduce eyelid inflammation, improve Meibomian gland function and reduce accumulated biofilm and debris along the eyelid margins.
Importantly, the study authors also noted that larger studies and longer follow-up remain necessary. BlephEx® should therefore be considered an adjunctive treatment approach.
A Broader Approach to Recurrent Chalazion
For patients with recurrent chalazion, management often extends beyond treatment of an isolated eyelid lump.
Assessment of associated blepharitis, Meibomian gland dysfunction, Demodex-associated eyelid disease and ocular surface inflammation may be important in reducing recurrence and improving long-term eyelid health.
Depending on the individual clinical findings, management may involve:
warm compresses
lid hygiene
treatment of blepharitis
management of Meibomian gland dysfunction
Demodex-directed therapy
dry eye treatment
procedural therapies such as BlephEx® in selected patients
As understanding of chronic eyelid margin disease continues to evolve, treatments directed at the underlying eyelid environment are likely to have increasing role in the management of recurrent chalazion.
Comments